TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 79 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $600,253 | +40.5% | 14,367 | +26.8% | 0.00% | +50.0% |
| Q3 2023 | $427,367 | +14.3% | 11,333 | +101.5% | 0.00% | -33.3% |
| Q2 2020 | $374,000 | -2.6% | 5,623 | -10.4% | 0.00% | 0.0% |
| Q1 2020 | $384,000 | -24.4% | 6,275 | +8.7% | 0.00% | -25.0% |
| Q4 2019 | $508,000 | -9.9% | 5,775 | -22.7% | 0.00% | 0.0% |
| Q3 2019 | $564,000 | +4.8% | 7,475 | +18.7% | 0.00% | +33.3% |
| Q2 2019 | $538,000 | -28.4% | 6,300 | -9.4% | 0.00% | -40.0% |
| Q1 2019 | $751,000 | -6.8% | 6,950 | -27.0% | 0.01% | 0.0% |
| Q4 2018 | $806,000 | -38.9% | 9,525 | -29.1% | 0.01% | -28.6% |
| Q3 2018 | $1,320,000 | -10.5% | 13,425 | +5.3% | 0.01% | -12.5% |
| Q2 2018 | $1,475,000 | +98.5% | 12,750 | +150.0% | 0.01% | +60.0% |
| Q2 2016 | $743,000 | – | 5,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 94,031 | $10,164,000 | 2.02% |
| ALTERNA WEALTH MANAGEMENT, INC | 20,530 | $2,219,000 | 1.88% |
| Strategic Global Advisors, LLC | 72,308 | $7,816,000 | 1.64% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $3,074,000 | 0.95% |
| Freestone Capital Holdings, LLC | 129,757 | $14,025,000 | 0.83% |
| Hudson Capital Management LLC | 12,394 | $1,339,667,000 | 0.82% |
| FORT, L.P. | 19,158 | $2,071,000 | 0.42% |
| MENTA CAPITAL LLC | 6,880 | $744,000 | 0.32% |
| Empirical Finance, LLC | 9,511 | $1,028,000 | 0.26% |
| ALGERT GLOBAL LLC | 4,071 | $440,000 | 0.25% |